Loading…

Rare FLT3 deletion mutants may provide additional treatment options to patients with AML: an approach to individualized medicine

Saved in:

Bibliographic Details
Published in:	Leukemia 2015-12, Vol.29 (12), p.2434-2438
Main Authors:	Chatain, N, Perera, R C, Rossetti, G, Rossa, J, Carloni, P, Schemionek, M, Haferlach, T, Brümmendorf, T H, Schnittger, S, Koschmieder, S
Format:	Article
Language:	English
Subjects:	13/95 631/67/1990/283/1897 631/67/395 692/699/67/1059 692/699/67/68 82/29 96/106 96/2 Cancer Research Critical Care Medicine Deletion mutant Enzymes fms-Like Tyrosine Kinase 3 - chemistry fms-Like Tyrosine Kinase 3 - genetics Gene Deletion Gene mutations Genetic aspects Health aspects HEK293 Cells Hematology Humans Intensive Internal Medicine letter-to-the-editor Leukemia, Myeloid, Acute - drug therapy Leukemia, Myeloid, Acute - genetics Medicine Medicine & Public Health Mutants Mutation Oncology Phosphotransferases Precision Medicine Regulation Tyrosine
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!